Multipl Skleroz Epidemiyolojisi

Ramaglia V, Rojas O, Naouar I, Gommerman JL. The Ins and Outs of Central Nervous System Inflammation-Lessons Learned from Multiple Sclerosis. Annu Rev Immunol. 2021;39:199-226.

Cook SD. Multiple sclerosis. Arch Neurol. 1998;55(3):421-423.

Fisher KS, Cuascut FX, Rivera VM, Hutton GJ. Current Advances in Pediatric Onset Multiple Sclerosis. Biomedicines. 2020;8(4):71.

Brola W, Steinborn B. Pediatric multiple sclerosis - current status of epidemiology, diagnosis and treatment. Neurol Neurochir Pol. 2020;54(6):508-517.

Jeong A, Oleske DM, Holman J. Epidemiology of Pediatric-Onset Multiple Sclerosis: A Systematic Review of the Literature. J Child Neurol. 2019;34(12):705-712.

Renoux C, Vukusic S, Confavreux C, et al. Adult Neurology Departments KIDMUS Study Group. Natural history of multiple sclerosis with childhood onset. N Engl J Med. 2007; 356(25): 2603–2613.

Gadoth N. Multiple sclerosis in children. Brain Dev. 2003;25(4):229-232.

Simpson S Jr, Blizzard L, Otahal P, Van der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011;82(10):1132-1141.

Portaccio E, Magyari M, Havrdova EK, et al. Multiple sclerosis: emerging epidemiological trends and redefining the clinical course. Lancet Reg Health Eur. 2024;44:100977.

An Q, Fan CH, Xu SM. Childhood multiple sclerosis: clinical features and recent developments on treatment choices and outcomes. Eur Rev Med Pharmacol Sci. 2018;22(17):5747-5754.

Carod-Artal FJ. The epidemiology of multiple sclerosis in the Scottish Highlands: Prevalence, incidence and time to confirmed diagnosis and treatment initiation. Mult Scler Relat Disord. 2021;47:102657.

Rotstein DL, Marrie RA, Maxwell C, et al. MS risk in immigrants in the McDonald era: A population-based study in Ontario, Canada. Neurology. 2019;93(24):e2203-e2215.

Ward M, Goldman MD. Epidemiology and Pathophysiology of Multiple Sclerosis. Continuum (Minneap Minn). 2022;28(4):988-1005.

Yeh W, Gresle M, Jokubaitis V, et al. Immunoregulatory effects and therapeutic potential of vitamin D in multiple sclerosis. Br J Pharmacol 2020;177(18):4113–4133.

Van Amerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58:1095.

Tremlett H, Zhu F, Ascherio A, Munger K. Sun exposure over the life course and associations with multiple sclerosis. Neurology 2018;90(14):e1191–e1199.

Sebastian P, Cherbuin N, Barcellos LF, et al. Association between time spent outdoors and risk of multiple sclerosis. Neurology 2022;98:e267–e278.

Lucas R, Ponsonby A, Dear K, et al. Sun exposure and vitamin D are independent risk factors for CNS demyelination. Neurology 2011;76(6):540–548.

Mowry EM, Krupp LB, Milazzo M, et al. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010; 67:618.

Olsson T, Barcellos L, Alfredsson L, et al. Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 2017;13(1):25–36.

Waubant E, Lucas R, Mowry E, et al. Environmental and genetic risk factors for MS: an integrated review. Ann Clin Transl Neurol 2019;6(9):1905–1922.

Bjornevik K, Cortese M, Healy BC, et al. Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis. Science 2022;375:296–301. doi:10.1126/science.abj8222

Belbasis L, Bellou V, Evangelou E, et al. Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses. Lancet Neurol 2015;14(3):263–273.

Marcucci S, Obeidat A. EBNA1, EBNA2, and EBNA3 link Epstein-Barr virus and hypovitaminosis D in multiple sclerosis pathogenesis. J Neuroimmunol 2020;339:577116.

Ramanujam R, Hedstrom A, Manouchehrinia A, et al. Effect of smoking cessation on multiple sclerosis prognosis. JAMA Neurol 2015;72(10):1117–1123.

Barzegar M, Najdaghi S, Ashari-Safavi A, et al. Early predictors of conversion to secondary progressive multiple sclerosis. Mult Scler Relat Disord 2021;54:103115.

Liu Z, Zhang T, Yu J, et al. Excess body weight during childhood and adolescence is associated with the risk of multiple sclerosis: a meta-analysis. Neuroepidemiology 2016;47(2):103–108.

Brenton N, Woolbright E, Briscoe-Abath C, et al. Body mass index trajectories in pediatric multiple sclerosis. Dev Med Child Neurol 2019;61(11):1289–1294.

Fitzgerald K, Salter A, Tyry T, et al. Measures of general and abdominal obesity and disability severity in a large population of people with multiple sclerosis. Mult Scler 2020;26(8):976–986.

Mowry EM, Glenn JD. The dynamics of the gut microbiome in multiple sclerosis in relation to disease. Neurol Clin 2018;36(1):185–196.

Dopkins N, Nagarkatti P, Nagarkatti M, et al. The role of gut microbiome and associated metabolome in the regulation of neuroinflammation in multiple sclerosis and its implications in attenuating chronic inflammation in other inflammatory and autoimmune disorders. Immunology 2018;154(2):178–185.

Khan O, Williams MJ, Amezcua L, et al. Multiple sclerosis in US minority populations: clinical practice insights. Neurol Clin Pract 2015;5(2):132–142.

Wallin M, Culpepper W, Coffman P, et al. The Gulf War era multiple sclerosis cohort: age and incidence rates by race, sex and service. Brain 2012;135(Pt 6):1778–1785.

Langer-Gould A, Gonzales E, Smith J, Li B, Nelson L. Racial and ethnic disparities in multiple sclerosis prevalence [published ahead of print April 28, 2022]. Neurology.

Cree B, Khan O, Bourdette D, et al. Clinical characteristics of African Americans vs Caucasian Americans with multiple sclerosis. Neurology 2004;63(11):2039–2045.

Gray-Roncal K, Fitzgerald KC, Zhovtis Ryerson L, et al. Association of disease severity and socioeconomic status in Black and White Americans with multiple sclerosis. Neurology 2021;97(9):e881–e889.

Saadi A, Himmelstein DU, Woolhandler S, Mejia NI. Racial disparities in neurologic health care access and utilization in the United States. Neurology 2017;88(24):2268–2275.

Wang Y, Tian F, Fitzgerald K, et al. Socioeconomic status and race are correlated with affective symptoms in multiple sclerosis. Mult Scler Relat Disord 2020;41:102010.

Harding KE, Wardle M, Carruthers R, et al. Socioeconomic status and disability progression in multiple sclerosis: a multinational study. Neurol 2019;92(13):e1497–e1506.

Calocer F, Dejardin O, Kwiatkowski A, et al. Socioeconomic deprivation increases the risk of disability in multiple sclerosis patients. Mult Scler Relat Disord 2020;40:101930.